comparemela.com

Latest Breaking News On - Pharma stock down - Page 21 : comparemela.com

Amryt Pharma plc (NASDAQ:AMYT) Short Interest Up 56 2% in March

Amryt Pharma plc (NASDAQ:AMYT – Get Rating) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 121,200 shares, a growth of 56.2% from the February 28th total of 77,600 shares. Based on an average daily volume of 646,300 shares, the days-to-cover ratio is […]

ABVC BioPharma (OTCMKTS:ABVC) Trading Down 1 6%

ABVC BioPharma, Inc. (OTCMKTS:ABVC – Get Rating)’s stock price fell 1.6% during mid-day trading on Friday . The stock traded as low as $0.60 and last traded at $0.61. 36,441 shares changed hands during mid-day trading, a decline of 96% from the average session volume of 914,569 shares. The stock had previously closed at $0.62. […]

China Pharma (NYSE:CPHI) Receives New Coverage from Analysts at StockNews com

StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Get Rating) in a research note released on Wednesday morning. The firm issued a hold rating on the stock. China Pharma Stock Down 4.1 % Shares of CPHI stock opened at $0.36 on Wednesday. China Pharma has a twelve month low of $0.33 and a […]

ImmuPharma (LON:IMM) Share Price Passes Below 200 Day Moving Average of $2 81

Should You Buy or Sell ImmuPharma Stock? Get The Latest IMM Stock Forecast, Price Target, Earnings Estimates, and Headlines at MarketBeat.

CTI BioPharma Corp (NASDAQ:CTIC) CEO Adam R Craig Sells 84,683 Shares

CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) CEO Adam R. Craig sold 84,683 shares of CTI BioPharma stock in a transaction dated Tuesday, January 3rd. The stock was sold at an average price of $6.01, for a total value of $508,944.83. Following the completion of the sale, the chief executive officer now directly owns 29,440 […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.